Knowledge gaps and emerging research areas in intrauterine growth restriction-associated brain injury

Bobbi Fleiss, Flora Wong, Fiona Brownfoot, Isabelle K. Shearer, Olivier Baud, David W. Walker, Pierre Gressens, Mary Tolcos

Research output: Contribution to journalReview ArticleResearchpeer-review

13 Citations (Scopus)


Intrauterine growth restriction (IUGR) is a complex global healthcare issue. Concerted research and clinical efforts have improved our knowledge of the neurodevelopmental sequelae of IUGR which has raised the profile of this complex problem. Nevertheless, there is still a lack of therapies to prevent the substantial rates of fetal demise or the constellation of permanent neurological deficits that arise from IUGR. The purpose of this article is to highlight the clinical and translational gaps in our knowledge that hamper our collective efforts to improve the neurological sequelae of IUGR. Also, we draw attention to cutting-edge tools and techniques that can provide novel insights into this disorder, and technologies that offer the potential for better drug design and delivery. We cover topics including: how we can improve our use of crib-side monitoring options, what we still need to know about inflammation in IUGR, the necessity for more human post-mortem studies, lessons from improved integrated histology-imaging analyses regarding the cell-specific nature of magnetic resonance imaging (MRI) signals, options to improve risk stratification with genomic analysis, and treatments mediated by nanoparticle delivery which are designed to modify specific cell functions.

Original languageEnglish
Article number188
Number of pages24
JournalFrontiers in Endocrinology
Issue numberMAR
Publication statusPublished - 1 Jan 2019


  • Brain development
  • Growth restriction
  • Neurobiology and brain physiology
  • Neuroinflammation
  • Neuroprotection

Cite this